Proprietary blends and undisclosed amounts on the performance shelf

What this shelf looks like when you read the panels

Amount disclosure on a supplement label comes in a handful of recognisable formats, and it is worth naming them before this one is placed among them. A label can print an amount beside every name. It can print a proprietary blend: one total weight, several names beneath it, no split. It can print a panel with serving lines and no amounts at all. And a product can arrive with no panel supplied at any point, which is where this one sits. This site has not surveyed the shelf and publishes no count of how common each format is.

The format is not the same as the quality of the product, and it is worth saying that plainly. A blend can sit on an excellent formula and a fully disclosed panel can sit on a weak one. What the format decides is narrower and more useful: how much of the product a buyer is permitted to check before paying for it.

That is what this post is about: not anyone’s intent, which would be invented, but the practical consequence of each format when you sit down with a government page and try to do some work.

Arginine: the claim, the finding, and the only number anywhere

Start with the ingredient whose claim is the most mechanical, because it shows the structure of the problem cleanly.

The NIH fact sheet on supplements for exercise and athletic performance is direct about the claim sellers make for arginine: that larger amounts improve performance, partly because the body converts arginine into nitric oxide, which expands blood vessels and increases blood flow. That is the mechanism paragraph on most listings in this category, printed on a government page as a description of what sellers say.

Then the finding. Although the research is limited, arginine supplements seem to have little to no effect on strengthening and muscle-building exercises or aerobic activities. Notice how much work the word larger is doing in the claim, and that the claim is about amounts while the label prints none.

The same page gives the only quantity that appears anywhere near this ingredient: arginine seems safe up to 9 grams a day for several days or weeks, and more than that can cause digestive discomfort and slightly lower blood pressure. That figure belongs to a government page, not to this bottle. With no amount printed there is nothing here to hold against it.

A blend is a gap. No panel at all is a wider one

A proprietary blend gets criticised often, and mostly fairly. It is worth being clear that no panel at all is a wider gap than a blend, not a narrower one.

Give a reader a blend total and they can still do four things. They can divide by the number of names to get an average. They can say the heaviest ingredient is at least that average. They can say the lightest is at most that average. And they can compare the total with a different product’s total, which at least ranks two bottles by how much active material is in each serving.

On this label all four are unavailable, because there is nothing to divide. Six names, no figures, no total. It is the one situation where the arithmetic that rescues a blend cannot be started.

None of which says anything about intent. A missing panel may be a supply problem, a listing problem or a decision, and this site does not know which. The label page records what is missing without a theory attached.

The category fact, stated carefully

One more fact belongs on this page, and it needs stating carefully enough that it cannot be misread.

The Food and Drug Administration publishes notifications about sexual enhancement products found to contain undeclared prescription drug ingredients. That is a fact about the shelf this product is sold on, not about this product. Nothing we have read says Alpha Erec has been tested or named in any notification, and nothing on this site suggests it has.

What it means in practice is that the shelf this product sits on has a documented history of undeclared ingredients, and the notifications are public. The FDA publishes those notifications on its own page. You can read the list yourself, which is better than taking anyone’s summary of it.

The connection to amounts is indirect but real. A label with declared amounts gives a buyer, a pharmacist or a laboratory something to check a product against. A label without them gives nobody anything to check. That is an argument for published amounts in general. It is not, and is not being used as, a statement about this product.